An increase in p50/p65 NF-kB Binding to the HIV-1 LTR Is Not Sufficient to Increase Viral Expression in the Primary Human Astrocyte

doi:10.1006/viro.1994.1685

Virology

Volume 205, Issue 2, December 1994, Pages 586-590

https://doi.org/10.1006/viro.1994.1685 Get rights and content

Abstract

Human astrocytes can be infected with HIV-1 both in vivo and in vitro. The amount of HIV-1 p24 structural protein production is low in comparison to that of the macrophage. Several weeks following infection or transfection, however, cocultivation with uninfected lymphocytes or stimulation with the cytokines TNF-α and IL1-β will increase viral production from this cell type. In the present study we demonstrate that phorbol 12-myristate 13-acetate (PMA) also increases HIV-1 p24 production from the primary human astrocyte. Using electrophoretic mobility shift assay (EMSA) in combination with supershift studies using specific antibodies, we demonstrate that PMA, Pike TNF-α, increases the p50/p65 form of NF-kB. Furthermore we demonstrate that the protein kinase inhibitor H7 inhibits PMA- and TNF-α-associated increases in HIV-1 expression at a time when it has little to no inhibitory effect on the associated increases in p50/p65 NF-kB. Thus, unless p50/p65 NF-kB or its binding is affected by H7 in a manner that cannot be resolved by EMSA, an increase in this form of NF-kB is not always sufficient to increase HIV-1 expression from the astrocyte.

References (0)

Cited by (19)

Human iPSC-derived brain organoids: A 3D mini-brain model for studying HIV infection
2023, Experimental Neurology
The brain is one of the important reservoir sites for HIV persistent/latent infection that often leads to HIV-associated neurocognitive disorders (HAND). However, HIV dynamics in the brain is an understudied area and little is known about mechanisms underlying the development and progression of HAND. This issue is mainly due to the lack of suitable in vitro models that can recapitulate the cellular and molecular complexity of the human brain. Hence, there is an urgent need for such models to study HIV neuropathogenesis and to develop therapeutics for HAND. The emergence of three-dimensional (3D) brain organoids generated from induced pluripotent stem cells (iPSCs) has now provided a clinically relevant in vitro model to study HIV brain infection and neuropathogenesis. Recently, there have been a noticeable number of publications that demonstrate the feasibility and advantages of this model for studies of neurobiology and brain disorders as well as HIV infection. Here, we describe the development of iPSC-derived human microglia-containing brain organoids, including advantages/challenges, and focus on their applicability for modeling HIV brain infection.
Interactions of HIV and drugs of abuse. The importance of glia, neural progenitors, and host genetic factors
2014, International Review of Neurobiology
Citation Excerpt :
A number of hypotheses have been put forth in an attempt to explain fundamental differences in the regulation of HIV infectivity by astroglia. The activation of NF-κB was proposed to play a less central role in driving viral production by astrocytes than in microglia (Conant, Atwood, Traub, Tornatore, & Major, 1994). Subsequent studies also suggested differences in Rev–astroglial RNA helicase DDX1 interactions (Fang et al., 2005).
Considerable insight has been gained into the comorbid, interactive effects of HIV and drug abuse in the brain using experimental models. This review, which considers opiates, methamphetamine, and cocaine, emphasizes the importance of host genetics and glial plasticity in driving the pathogenic neuron remodeling underlying neuro-acquired immunodeficiency syndrome and drug abuse comorbidity. Clinical findings are less concordant than experimental work, and the response of individuals to HIV and to drug abuse can vary tremendously. Host-genetic variability is important in determining viral tropism, neuropathogenesis, drug responses, and addictive behavior. However, genetic differences alone cannot account for individual variability in the brain “connectome.” Environment and experience are critical determinants in the evolution of synaptic circuitry throughout life. Neurons and glia both exercise control over determinants of synaptic plasticity that are disrupted by HIV and drug abuse. Perivascular macrophages, microglia, and to a lesser extent astroglia can harbor the infection. Uninfected bystanders, especially astroglia, propagate and amplify inflammatory signals. Drug abuse by itself derails neuronal and glial function, and the outcome of chronic exposure is maladaptive plasticity. The negative consequences of coexposure to HIV and drug abuse are determined by numerous factors including genetics, sex, age, and multidrug exposure. Glia and some neurons are generated throughout life, and their progenitors appear to be targets of HIV and opiates/psychostimulants. The chronic nature of HIV and drug abuse appears to result in sustained alterations in the maturation and fate of neural progenitors, which may affect the balance of glial populations within multiple brain regions.
Role of CD23 in astrocytes inflammatory reaction during HIV-1 related encephalitis
2001, Cytokine
Soluble factors released by intra-cerebral activated cells are implicated in neuronal alterations during central nervous system inflammatory diseases. In this study, the role of the CD23 pathway in astrocyte activation and its participation in human immunodeficiency virus-1 (HIV-1)-induced neuropathology were evaluated. In human primary astrocytes, CD23 protein membrane expression was dose-dependently upregulated by gp120. It was also upregulated by gamma-interferon (γ-IFN) and modulated by interleukin-1-beta (IL-1β) whereas microglial cells in these stimulation conditions did not express CD23. Cell surface stimulation of CD23 expressed by astrocytes induced production of nitric oxide (NO) and IL-1β which was inhibited by a specific inducible NO-synthase (iNOS) inhibitor (aminoguanidine), indicating the implication of this receptor in the astrocyte inflammatory reaction. On brain tissues from five out of five patients with HIV-1-related encephalitis, CD23 was expressed by astrocytes and by some microglial cells, whereas it was not detectable on brain tissue from five of five HIV-1-infected patients without central nervous system (CNS) disease or from two of two control subjects. In addition, CD23 antigen was co-localized with iNOS and nitrotyrosine on brain tissue from patients with HIV1-related encephalitis, suggesting that CD23 participates in iNOS activation of astrocytes in vivo. In conclusion, CD23 ligation is an alternative pathway in the induction of inflammatory product synthesis by astrocytes and participates in CNS inflammation.
ErbB2 activation upregulates glutaminase 1 expression which promotes breast cancer cell proliferation
2014, Journal of Cellular Biochemistry
Contribution of TRPV1 to microglia-derived IL-6 and NFκB translocation with elevated hydrostatic pressure
2008, Investigative Ophthalmology and Visual Science
Pressure-induced regulation of IL-6 in retinal glial cells: Involvement of the ubiquitin/proteasome pathway and NFκB
2006, Investigative Ophthalmology and Visual Science

View all citing articles on Scopus

View full text

Short CommunicationsAn increase in p50/p65 NF-kB Binding to the HIV-1 LTR Is Not Sufficient to Increase Viral Expression in the Primary Human Astrocyte

Abstract

Short Communications
An increase in p50/p65 NF-kB Binding to the HIV-1 LTR Is Not Sufficient to Increase Viral Expression in the Primary Human Astrocyte